Annovis Year-End Investor Webcast on December 11, 2024
Annovis CEO Discusses Breakthrough Drug for Neurodegenerative Diseases on Today's Marketplace
Annovis Bio Web Cast 6/11/2024
Annovis (ANVS) featured on Money Matters 6/14/24
Annovis Bio's Breakthroughs in Alzheimer's and Parkinson's: Full Pitch and Q&A on Virtual Investor
Annovis Bio Presents Promising Phase III Parkinson’s Data
Stay Updated with Annovis Bio, Inc. (NYSE: ANVS)
Join the Annovis Bio Newsletter to receive the latest updates on our groundbreaking research and developments in neurodegenerative diseases like Alzheimer's and Parkinson's
Thanks for joining our newsletter
Oops! Something went wrong while submitting the form.
.webp){kind=small}
.svg)
.svg)
.svg)
.svg)
